120 likes | 175 Views
Etiological Agents Causing Myocarditis Viral (Most Common) Adenovirus Coxsackie virus/Enterovirus Cytomegalovirus Parvovirus B19 Hepatitis C virus Influenza Human immunodeficiency virus Herpes virus Epstein-Barr virus Mixed infections . Bacterial
E N D
Etiological Agents Causing Myocarditis • Viral (Most Common) • Adenovirus • Coxsackie virus/Enterovirus • Cytomegalovirus • Parvovirus B19 • Hepatitis C virus • Influenza • Human immunodeficiency virus • Herpes virus • Epstein-Barr virus • Mixed infections
Bacterial • Mycobacterial species • Chlamydia pneumoniae • Streptococcal species • Mycoplasma pneumoniae • Treponema pallidum • Fungal • Aspergillus • Candida • Coccidioides • Cryptococcus • Histoplasma • ProtozoalTrypanosoma cruzi • Parasitic Schistosomiasis Larva migrans
Toxins Anthracyclines Cocaine Hypersensitivity Clozapine Sulfonamides Cephalosporins Penicillins ricyclic antidepressants Autoimmune Activation Smallpox vaccination Giant cell myocarditis Churg-Strauss syndrome Sjögren syndrome Inflammatory bowel disease Celiac disease Sarcoidosis Systemic lupus erythematosus Takayasu arteritis Wegener granulomatosis
Expanded Criteria for Diagnosis of Myocarditis • Suspicious for myocarditis = 2 positive categoriesCompatible with myocarditis = 3 positive categories • High probability of being myocarditis = all 4 categories positive(Any matching feature in category = positive for category) Category I: Clinical Symptoms • Clinical heart failure • Fever • Viral prodrome • Fatigue • Dyspnea on exertion • Chest pain • Palpitations • Presyncope or syncope
Category II: Evidence of Cardiac Structural/Functional Perturbation in the Absence of Regional Coronary Ischemia • Echocardiography evidence • Regional wall motion abnormalities • Cardiac dilation • Regional cardiac hypertrophy • Troponin release High sensitivity (>0.1 ng/ml) • Positive indium-111 antimyosin scintigraphy and Normal coronary angiography or Absence of reversible ischemia by coronary distribution on perfusion scan
Category III: Cardiac Magnetic Resonance Imaging I • ncreased myocardial T2 signal on inversion recovery sequence • Delayed contrast enhancement following gadolinium-DTPA infusion Category IV: Myocardial Biopsy—Pathological or Molecular Analysis • Pathology findings compatible with Dallas criteria • Presence of viral genome by polymerase chain reaction or in situ hybridization
Comparison of Efficacy of Various Diagnostic Modalities for Myocarditis • Diagnostic Modality Sensitivity Range Specificity Range • ECG changes (e.g., AV block, Q, ST changes) 47% ? • Troponin (lower threshold of >0.1 mg/ml) 34%-53% 89%-94% • CK-MB 6% ? • Antibodies to virus or myosin 25%-32% 40% • Indium-111 antimyosin scintigraphy 85%-91% 34%-53% • Echocardiography (ventricular dysfunction) 69% ? • Cardiac magnetic resonance imaging 86% 95% • Myocardial biopsy (Dallas criteria of pathology) 35%-50% 78%-89% • Myocardial biopsy (viral genome by PCR) 38%-65% 80%-100% • ? = indeterminant or poor; AV = atrioventricular; CK-MB = cytosine kinase isoenzyme; ECG = electrocardiogram; PCR = polymerase chain reaction.